JENNA HODGSON: Open Payments
NPI 1679270722 · LEXINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$920 in 50 payments from 14 companies in 2025. Trend: 2023 $711 · 2024 $778 · 2025 $920
Food & beverage: $920
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $222 |
| Novo Nordisk Inc | 11 | $186 |
| ABBVIE INC. | 4 | $95 |
| Grifols USA, LLC | 3 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
| Lilly USA, LLC | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Corcept Therapeutics | 1 | $21 |
Products named: Ozempic, NURTEC ODT, ELIQUIS, Prolastin-C Liquid, QULIPTA, REXULTI, PREVNAR 20, BREZTRI.
Industry payments across NC — which companies pay providers there.
